Groundbreaking HIV cure trial at UKZN reveals hopeful outcomes for patients
UKZN's groundbreaking HIV cure trial in Durban reveals promising results, potentially revolutionising treatment strategies for HIV in Africa.
Pulmonology Advisor1d
Ensitrelvir Effective for COVID-19 Prevention in Exposed Household Contacts
Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.
The Citizen9d
First HIV cure clinical trial in Africa shows promise in women
Dar/Nairobi. A ground-breaking HIV clinical trial in Africa has demonstrated that some women can control the virus without ...
News2412d
A jab that could protect against HIV for a year at a time
A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
Too Old to Operate14d
Ensitrelvir Effectively Prevents Spread of COVID-19 in Households
taking ensitrelvir within 72 hours of symptoms is effective at preventing infection and generally well tolerated, according to a study presented at the annual Conference on Retroviruses and ...
Medscape15d
Twice Daily TB Therapies Show Similar Neuropsychiatric Outcomes in Patients with HIV
Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being ...
The Citizen15d
Groundbreaking HIV trial shows patients can control virus without ART
The results of the study were presented at the 2025 Conference on Retroviruses and Opportunistic Infections, underway in San Francisco, US. According to Ndungu, the study tested a promising HIV ...
AllAfrica.com15d
Africa: A Jab That Could Protect Against HIV for a Year At a Time, and Other Highlights From Major Conference
Spotlight reports on this and some of the other exciting research on long-acting anti-HIV medicines presented at the Conference on Retroviruses and Opportunistic Infections. Several new ...